- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Abbott Laboratories (ABT)
by latest | most commented
-
Stocks on My Watchlist: Apple, Google, Cardinal Health
-
Pharmas, Hospitals Fall Due to Health Care Reform Troubles
-
Alternate Short Strategy: Put Protection for Less (Part II)
-
When Timing Meets Opportunity: Which Dividend Achievers Are at a 52-Week Low?
-
Dividend Investors: Take S&P 500 Quarterly Reviews with a Grain of Salt
-
12 Dividend Stocks to Own in This Market
-
Comparing Medicine’s Cost and Effectiveness
-
Closing Update for Tuesday June 30
-
Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines
-
5 Dividend Aristocrats That Have Been There Before
-
Abbott Falls After Losing Patent Case
-
Wall Street Breakfast: Must-Know News
-
2009 Fortune 40 Best Stocks for Retirement: Part I
-
Eminence Making a Lab Services Bet?
-
81 Dividend Growers to Consider
-
51 Option Ideas for Bears
-
Fortune's 40 Best Stocks to Retire On
-
Redefining Pharma as Biotech Dominates Industry's Growth
-
Biotech Set to Dominate Drug Industry Growth
-
Seven Laggard Biotech Trades
-
Filtered Equity Income Stock Prospects
-
6 Healthcare Stocks to Watch
-
The Long Case for Abbott Laboratories
-
Wednesday's Healthcare Market Movers
-
FDA Calendar Updates: ABT, AFFY, AZN, LLY, MELA, PFE, SOMX, VPHM
-
How to Replace Sold Dividend Stocks
-
Diversifying into Small and Mid Cap Dividend Stocks
-
Johnson & Johnson: Strong Pipeline, Compelling Valuation
-
The Next Bull Market Is 4-8 Months Away
-
Why You Should Stick With the Dollar and the U.S.
-
Dividend Investing vs. Trading
-
Ken Heebner's First Quarter 2009 Moves
-
S&P Dividend Aristocrats Getting Through the Credit Crisis
-
Dividends: A Company's Leading Indicator
-
Broader Market Outperforming Dividend Aristocrats
-
Dividends Survive Despite Recession
-
'TechCheck' for Top Rated U.S. Stocks
-
Medtronic's Healthy Future - Barron's
-
China: Latest Hotspot for Western Biotech, Pharma Firms
-
Best Stocks of 2009 Review: The First Third
-
Dividend Portfolio Update: April 2009